- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.04. | CRYO-CELL International GAAP EPS of $0.07 beats by $0.13, revenue of $7.85M misses by $0.1M | 1 | Seeking Alpha | ||
| 15.04. | CRYO CELL INTERNATIONAL INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 15.04. | Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results | 50 | Business Wire | OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world's first private cord blood bank to separate and store stem cells in 1992, announced... ► Artikel lesen | |
| 26.03. | CRYO CELL INTERNATIONAL INC - 8-K, Current Report | 1 | SEC Filings | ||
| 25.03. | Cryo-Cell plans to explore strategic alternatives and spin-off its Celle Corp unit | 3 | Seeking Alpha | ||
| 25.03. | Cryo-Cell Plans To Explore Strategic Alternatives And Spin-off Of Celle Subsidiary | 2 | RTTNews | ||
| 28.02. | CRYO-CELL International GAAP EPS of -$1.14 misses by $1.26, revenue of $31.3M misses by $0.08M | 1 | Seeking Alpha | ||
| 28.02. | CRYO CELL INTERNATIONAL INC - 10-K, Annual Report | 1 | SEC Filings | ||
| 28.02. | Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023 | 100 | Business Wire | OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world's first private cord blood bank to separate and store stem cells in 1992, announced... ► Artikel lesen | |
| 12.10.23 | Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results | 280 | Business Wire | OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the "Company"), the world's first private cord blood bank to separate and store stem cells in 1992... ► Artikel lesen | |
| 14.07.23 | Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results | 338 | Business Wire | OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world's first private cord blood bank to separate and store stem cells in 1992, announced... ► Artikel lesen |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,400 | +4,18 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Aktie des Dialyseanbieters Fresenius Medical Care (FMC) auf "Underweight" mit einem Kursziel von 35,40 Euro belassen. US-Konkurrent Davita... ► Artikel lesen | |
| STRATEC | 41,700 | +2,08 % | Stratec: 3 Euro Aufschlag nach den Zahlen | Im ersten Quartal geht der Umsatz bei Stratec um 16 Prozent auf 51 Millionen Euro zurück. Das EBIT sinkt um 18 Prozent auf 3,1 Millionen Euro. Daraus ergibt sich eine Marge von 6,2 Prozent. Das zweite... ► Artikel lesen | |
| VITA 34 | 4,600 | -1,29 % | EQS-News: Vita 34 AG: Vita 34 kehrt 2023 auf Wachstumspfad zurück | EQS-News: Vita 34 AG
/ Schlagwort(e): Jahresergebnis
Vita 34 kehrt 2023 auf Wachstumspfad zurück
30.04.2024 / 22:51 CET/CEST
Für den Inhalt der Mitteilung ist der Emittent... ► Artikel lesen | |
| STRAUMANN | 121,40 | -2,35 % | Implantat-Hersteller Straumann mit schwierigem Quartal, Aktie verliert | ||
| M1 KLINIKEN | 16,000 | -3,03 % | EQS-Adhoc: M1 Kliniken AG: Aufsichtsrat stellt Jahresabschluss 2023 fest. Dividendenvorschlag in Höhe von EUR 0,50 je Aktie | EQS-Ad-hoc: M1 Kliniken AG / Schlagwort(e): Dividende/Prognose
M1 Kliniken AG: Aufsichtsrat stellt Jahresabschluss 2023 fest. Dividendenvorschlag in Höhe von EUR 0,50 je Aktie
07.05.2024... ► Artikel lesen | |
| ALCON | 75,37 | +0,05 % | Alcon Announces Results of 2024 Annual General Meeting | Shareholders approve dividend of CHF 0.24 per share Shareholders confirm F. Michael Ball as member and Chair of the Board of Directors as well as the other members who all stood for re-election... ► Artikel lesen | |
| BAXTER | 33,110 | -0,29 % | BAXTER INTERNATIONAL INC - 8-K, Current Report | ||
| DAVITA | 127,90 | +0,04 % | 6 Analysts Assess DaVita: What You Need To Know | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,030 | -10,43 % | Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results | SALT LAKE CITY, May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| TECAN GROUP | 337,20 | -0,71 % | Research and Markets: Europe DNA/RNA Sample Extraction and Isolation Market Analysis Report 2023-2033 Featuring F. Hoffmann-La Roche, MACHEREY-NAGEL, Merck, QIAGEN, & Tecan Group - ResearchAndMarkets.com | The "Europe DNA/RNA Sample Extraction and Isolation Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
The Europe DNA/RNA sample extraction and... ► Artikel lesen | |
| CYTOSORBENTS | 0,820 | -0,73 % | CytoSorbents Reports First Quarter 2024 Results | Product Sales up a robust 14% over prior year, and a significant 22% sequentiallyWe believe the STAR-T data presented at AATS support a favorable benefit-to-risk profile of DrugSorb-ATR in coronary... ► Artikel lesen | |
| SENSEONICS | 0,443 | -2,18 % | Senseonics, Rimidi partner on remote diabetes monitoring program | ||
| BIOCEPT | 6,800 | 0,00 % | NSE - BIOCEPT INC - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| UNIVERSAL HEALTH SERVICES | 166,00 | 0,00 % | UNIVERSAL HEALTH SERVICES INC - 10-Q, Quarterly Report |
CRYO-CELL INTERNATIONAL INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 7,500 Euro und damit +2,74 % im Plus. Aus der Ausschüttung der letzten 12 Monate von insgesamt 0,00 Euro errechnet sich eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
